Search clinical trials for: Amisulpride

Total 60 results

The Affiliated Hospital of Qingdao University

Recruiting

Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Schizophrenia | Bioequivalence

China
University of California, Los Angeles
PoloMar Health LLC

Not yet recruiting

An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms (AmisulprideTRS)

Schizophrenia, Treatment-Resistant
Qilu Pharmaceutical (Hainan) Co., Ltd.

Not yet recruiting

A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.

PONV
Acacia Pharma Ltd
Premier Research Group plc; Amicus CD LLC

Recruiting

Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

Nausea and Vomiting, Postoperative

Canada, United States, Germany, France
Simone Grimm
Boehringer Ingelheim; Charité Research Organisation GmbH

Not yet recruiting

Effects of a Single Dose of Amisulpride on Functional Brain Changes

Major Depressive Disorder
All India Institute of Medical Sciences, Bhubaneswar

Recruiting

Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression (PSD-AOFC)

Post-Schizophrenic Depression

India
Shanghai Mental Health Center
Shanghai Jiao Tong University School of Medicine

Not yet recruiting

Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

Schizophrenia

China
Tianjin Anding Hospital

Recruiting

Amisulpride Treatment for BPSD in AD Patients

BPSD | Amisulpride | Olanzapine | Dementia of the Alzheimer Type

China
Fundación Pública Andaluza para la gestión de la...

Active, not recruiting

Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (CLOZ-AID)

Intellectual Disability | Psychosis

Spain
University of California, San Diego

Active, not recruiting

Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa

Anorexia Nervosa

United States
susanne becker
SNSF

Completed

Psychobiological Mechanisms Underlying Chronic Pain

Fibromyalgia | Pain, Chronic | Chronic Pain, Widespread

Switzerland
Acacia Pharma Ltd
ArborMetrix

Withdrawn

Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment (PROMPT)

Nausea and Vomiting, Postoperative
Shanghai Mental Health Center
Shanghai Pudong New Area Mental Health Center; The Affiliated Brain Hospital...

Completed

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

Schizophrenia

China
Organon and Co

Completed

An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

Bipolar Disorder
Acacia Pharma Ltd

Completed

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Renal Disease, End Stage

United States
Snyder, Robert W., M.D., Ph.D., P.C.
Snyder Biomedical Corporation

Completed

Extension, Carbidopa-levodopa in Neovascular AMD

Retina | Macula; Degeneration

United States
Philipps University Marburg Medical Center
University of Hamburg-Eppendorf

Completed

Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.

Healthy Participants

Germany
Shanghai Mental Health Center

Unknown

Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia

Schizophrenia | Negative Symptom | Amisulpride | Gut Microbiomes
Shanghai Mental Health Center

Unknown

SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia

Treatment-resistant Schizophrenia

China
Haukeland University Hospital
Helse Vest

Completed

Bergen Psychosis Project 2 - The Best Intro Study (BP2)

Psychotic Disorders | Schizophrenia

Austria, Norway
Seoul National University Hospital

Unknown

[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis (DPTP)

Schizophrenia

Korea, Republic of
Heinrich-Heine University, Duesseldorf

Completed

Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy (COMBINE)

Schizophrenia | Schizoaffective Disorder

Germany
Acacia Pharma Ltd

Completed

US Phase III Study of APD421 in PONV

PONV

United States
Shanghai Mental Health Center

Unknown

Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia

Schizophrenia

China
Acacia Pharma Ltd

Completed

Thorough QT Study of Intravenous Amisulpride

Healthy
Technical University of Munich

Completed

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Schizophrenia | Schizoaffective Disorders | Schizophrenia and Disorders With Psychotic Features

Germany
Shanghai Mental Health Center

Unknown

Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime

Schizophrenia

China
Mclean Hospital
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

An Investigation of Early Life Stress and Depression

Major Depressive Disorder (MDD) | History of Childhood Sexual Abuse (CSA)

United States
Rene Kahn
King's College London; Ludwig-Maximilians - University of Munich; Technical University... and other collaborators

Completed

Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Netherlands, United Kingdom, Australia, Austria, Belgium, Bulgaria, Czechia, Denmark, France, Germany, Israel, Italy, Poland, Romania, Spain, Switzerland
Mclean Hospital
National Institute of Mental Health (NIMH)

Completed

The Effects of Dopamine on Reward Processing

Major Depressive Disorder (MDD)

United States
Central Institute of Mental Health, Mannheim
University of Cologne

Completed

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (CBD-IS)

Schizophrenia

Germany
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany
Emory University
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes...

Completed

Neurobiological Principles Applied to the Rehabilitation of Stroke Patients

Stroke

United States
Institute of Psychiatry, London

Terminated

Optimisation of Antipsychotic Drug Use in Older People

Schizophrenia | Alzheimer's Disease

United Kingdom
Birte Glenthoj
Rigshospitalet, Denmark; UMC Utrecht; Glostrup University Hospital, Copenhagen; Copenhagen Hospital Corporation and other collaborators

Completed

Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Denmark
University of Copenhagen
Rigshospitalet, Denmark; UMC Utrecht; Glostrup University Hospital, Copenhagen; Copenhagen Hospital Corporation and other collaborators

Completed

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) (PECANS)

Schizophrenia

Denmark
Kaohsiung Kai-Suan Psychiatric Hospital

Terminated

A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia

Schizophrenia

Taiwan
Sunovion

Completed

Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

Schizophrenia

United Kingdom
Geha Mental Health Center

Withdrawn

Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients (ClozAmi)

Schizophrenia | Treatment Resistant Disorders

Israel
University of Zurich

Completed

Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity

Addiction

Switzerland
Technical University of Munich

Completed

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Germany
Imperial College London
University College, London; University of Manchester

Completed

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia (AMICUS)

Schizophrenia

United Kingdom
Sanofi

Completed

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia (ESCAPE)

Schizophrenia

China
University of Cologne
German Federal Ministry of Education and Research; Heinrich-Heine University... and other collaborators

Completed

Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

Schizophrenia | Psychoses

Germany
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
GlaxoSmithKline

Completed

Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors

Obsessive-Compulsive Disorder

United Kingdom
CHA University
Handok Inc.

Unknown

Association of Amisulpride Response in Schizophrenia With Brain Image (ARB)

Schizophrenia | Schizophreniform Disorder
National Taiwan University Hospital
Yu-Li Hospital; Yu-Li Veterans Hospital

Completed

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Metabolic Syndrome X

Taiwan
Beersheva Mental Health Center
Tirat Carmel Mental Health Center

Completed

Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation (CIH)

Clozapine-induced Hypersalivation

Israel
Sanofi

Completed

Efficacy Study on Cognitive Functions in Schizophrenic Patients (AMIMIND)

Schizophrenia

Hungary

Search clinical trials for: Amisulpride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations